POLE and glioblastoma: However, inactivating POLE mutations and a hypermutator phenotype have been linked to increased immune response and better prognosis in GBM, anaplastic astrocytoma, pediatric brain tumors, and other malignancies41, 50, 51, including a case with an exceptionally good prognosis50.